AR
Insider
Arthur F Ryan
DirectorArthur F Ryan (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $130K of REGN (200 sh × $650.15, as filed), executed Jul 2.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$130K
shares × price, as filed
Last traded
Jul 2
Filed Jul 7
Median ADV $702.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $130K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
REGNRecent filings
REGNSALE
Regeneron Pharmaceuticals, Inc.
View filing →
$130K200 sh × $650.15
Exec Jul 2
Filed Jul 7 · 4:05 PM ET